Nanocage targets drug site bullseye; Supersized vaccine plant;

> A smart nanocage made of gold and covered with a smart polymer is light-activated to release its medicinal contents--a chemotherapy drug or bactericide, for example--only near the target tissue. Article

> Toronto-based Microbix Biosystems (MBX:TSX) and joint-venture partner Hunan Biopharmaceutical will build what they call "the world's third largest influenza vaccine facility." Announcement

> Russian drugmaker Materia Medica has again turned to contract manufacturer Angel Biotechnology (ABH.L), this time for process development and GMP manufacturing of certain antibodies. Release

> The Royal Pharmaceutical Society has joined forces with Pfizer to launch part two of the manufacturers' anti-counterfeiting campaign. Article

> The Motley Fool provides its unique insights in a face-off of the big three pharma industry distributors. Analysis

Suggested Articles

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.

A Chinese OTC drugmaker gets the distinction of ringing in the new year as the first company to be slapped with an FDA warning letter.